RANBP3L (RAN binding protein 3 like) functions as a nuclear export factor that plays a critical role in regulating BMP signaling and cell differentiation. The protein directly recognizes dephosphorylated SMAD1/5/8 and mediates their nuclear export in a Ran-dependent manner, thereby terminating BMP signaling 1. This regulatory mechanism is essential for controlling mesenchymal stem cell fate, as RANBP3L blocks osteoblast differentiation while promoting myogenic differentiation 1. The gene is regulated by NFAT5 under hyperosmotic conditions through direct promoter binding 2. RANBP3L demonstrates significant clinical relevance across multiple cancers, with lower expression associated with poor prognosis in hepatocellular carcinoma and serving as a potential biomarker 3. Loss of RANBP3L function leads to cellular transformation resembling renal clear cell carcinoma, including loss of epithelial structure, increased migration, and altered gene expression patterns 2. The protein also shows involvement in other pathological conditions, including renal ischemia-reperfusion injury through regulatory networks with transcription factors and miRNAs 4, and appears to have anti-tumor properties in breast cancer 5. These findings establish RANBP3L as a crucial regulator of cellular differentiation and a potential therapeutic target in cancer.